Federal Multi Criteria Decision Making Framework in Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients as Case Study
No specific treatment was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when the epidemic firstly broke out. The urgent need to end this unusual situation has resulted in many attempts to deal with SARS-CoV-2. In addition to several types of vaccinations that have been c...
Saved in:
| Main Author: | |
|---|---|
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://bspace.buid.ac.ae/handle/1234/2112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|